Rensel M, Zabeti A, Mealy MA, Cimbora D, et al. Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4-immunoglobulin G-seropositive participants taking inebilizumab for 4 years in the N-MOmentum trial. Mult Scler 2022;28:925-932.
PMID: 34595983